AbbVie ABBV
NYSE ABBV
$265.85 +4.02 (+1.54%)
As of: Aug 21, 2026 · 10:41 AM EDT

AbbVie (ABBV) EBIT Margin (2012 - 2026)

AbbVie (ABBV) posted quarterly EBIT Margin of 26.6% for Q1 2026, down 138.0% year-over-year from 69.99% in Q1 2025, and down 2.73% quarter-over-quarter from 27.34% in Q4 2025.

AbbVie (ABBV) EBIT Margin (2012 - 2026) Analysis & Trends

AbbVie (ABBV) has reported EBIT Margin for 15 consecutive years, with 26.6% the latest figure, recorded in Q1 2026.

  • In Q1 2026, EBIT Margin fell 138.0% year-over-year to 26.6%; the TTM figure through Mar 2026 stood at 24.41% (up 685.0% YoY), while the FY2025 annual figure was 24.65%, up 843.0% from the prior year.
  • EBIT Margin retreated to 26.6% in Q1 2026 per ABBV's latest filing, from 27.34% in the prior quarter.
  • Across five years, EBIT Margin topped out at 36.39% in Q4 2022 and bottomed at 9.87% in Q4 2024.
  • Historically, EBIT Margin has averaged 24.21% across 5 years, with a median of 26.6% in 2026.
  • Annual changes were most pronounced in 2024 — EBIT Margin sank 3221 bps — and 2025, when it jumped 3721 bps.
  • AbbVie's EBIT Margin stood at 36.39% in 2022, then tumbled by 39 bps to 22.34% in 2023, then slumped by 144 bps to 9.87% in 2024, then soared by 377 bps to 27.34% in 2025, then slipped by 3 bps to 26.6% in 2026.
  • Business Quant data shows ABBV's EBIT Margin at 26.6% in Q1 2026, 27.34% in Q4 2025, and 12.07% in Q3 2025.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) EBIT Margin (Qtr)
1 Johnson & Johnson 653.66 Bn 632.90 Bn 17.26 Bn 28.21%
2 AbbVie 470.02 Bn 463.46 Bn 12.70 Bn 37.86%
3 Merck 379.06 Bn 371.92 Bn 12.21 Bn -3.52%
4 Novartis Ag 302.95 Bn 295.26 Bn 11.24 Bn 32.97%
5 Astrazeneca 257.68 Bn 252.78 Bn 12.86 Bn 20.57%
6 Amgen 236.97 Bn 222.98 Bn 7.24 Bn 34.95%
7 Gilead Sciences 182.78 Bn 179.60 Bn 6.22 Bn -133.21%
8 Pfizer 161.51 Bn 149.81 Bn 10.94 Bn 28.37%
9 Gsk 105.54 Bn 101.37 Bn 8.24 Bn 5.72%
10 Sanofi 55.04 Bn 47.66 Bn 10.79 Bn 124.39%

Historic Data

Download Data
DateValue
Jun 30, 2026 37.86%
Mar 31, 2026 26.60%
Dec 31, 2025 27.34%
Sep 30, 2025 12.07%
Jun 30, 2025 31.73%
Mar 31, 2025 27.98%
Dec 31, 2024 -9.87%
Sep 30, 2024 26.49%
Jun 30, 2024 27.64%
Mar 31, 2024 22.73%
Dec 31, 2023 22.34%
Sep 30, 2023 16.38%
Jun 30, 2023 32.55%
Mar 31, 2023 22.64%
Dec 31, 2022 36.39%
Sep 30, 2022 31.08%
Jun 30, 2022 22.59%
Mar 31, 2022 34.84%
Dec 31, 2021 34.09%
Sep 30, 2021 30.02%